Recent strategies in the development of taxane anticancer drugs

Expert Opinion on Therapeutic Patents

Volumn 10, Issue 6, 2000, Pages 869-889

  Lin, S ^a   Ojima, I ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Antimitotic agents; Apoptosis; Cancer chemotherapy; Cytotoxicity; Docetaxel; Drug formulation; Multi drug resistance; Paclitaxel; Target delivery; Taxanes; Taxoids; Water lipid solubility

Indexed keywords

ANTINEOPLASTIC AGENT; BACCATIN III; GLYCOPROTEIN P; PACLITAXEL; PACLITAXEL DERIVATIVE; PHENYLISOSERINE; TAXTERE; UNCLASSIFIED DRUG;

BREAST CANCER; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG POTENCY; DRUG SOLUBILITY; MULTIDRUG RESISTANCE; OVARY CANCER; REVIEW; SIDE EFFECT;

EID: 0034088338     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.10.6.869     Document Type: Review

References (59)